-
2025-522306-21-00
Cognitive profiles 4
-
2023-504746-54-00
AMYOTROPHIC LATERAL SCLEROSIS 3
-
2025-522957-20-00
Myotonic Dystrophy Type 1 5
-
2024-515598-82-00
Voltage-gated sodium channel type II alpha subunit (SCN 5
-
2023-508928-35-00
Hypoxic ischemic encephalopathy 10
-
2024-513411-27-00
Parkinson’s disease 1
-
2024-518822-33-01
Cerebral Palsy 6
-
2025-524822-16-00
Idiopathic intracranial hypertension 5
-
2024-518824-56-00
Complete to incomplete (AIS A-C) sub-acute cervical or 5
-
2025-520538-49-00
Moderate-Severe Hypoxic-Ischaemic Encephalopathy (HIE) 1
-
2025-520540-15-00
aneurysmal subarachnoid hemorrhage 4
-
2025-523828-51-00
CACNA1A Disorders 5
-
2024-517388-22-00
Agitation in Alzheimer's Disease Dementia 10
-
2025-524884-18-01
Intracranial aneurysms 5
-
2024-515627-10-00
generalised myasthenia gravis 7
-
2025-521175-31-00
Ocular manifestations of Neuronal Ceroid Lipofuscinosis 7
-
2024-516076-15-00
Infants with perinatal asphyxiation and indication to h 3
-
2024-513444-28-00
Acute ischaemic stroke due to basilar artery occlusion. 5
-
2025-524937-19-00
Coma due to acute brain injury 4
-
2024-516896-34-00
progressive/relapsed/refractory pediatric low-grade gli 9
-
2024-518865-85-00
Alzheimers Disease 4
-
2025-520587-18-00
Focal Onset Seizures 4
-
2025-522399-10-00
Vestibular neuritis 5
-
2024-519995-20-00
Maladie d' Alzheimer 10